Humacyte, Inc. (HUMA) Operating income 2020–2025
Humacyte, Inc. (HUMA) annual operating income history from SEC filings — each fiscal year as reported.
-$108.1MFY2025 · since FY2020: -$64.6M → -$108.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$108.1M | +5.5% |
| FY2024 | -$114.4M | -14.3% |
| FY2023 | -$100.0M | -18.3% |
| FY2022 | -$84.6M | -4.1% |
| FY2021 | -$81.2M | -25.7% |
| FY2020 | -$64.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More HUMA financial trends
HUMA RevenueHUMA Net incomeHUMA Net marginHUMA Gross profitHUMA Gross marginHUMA Operating marginHUMA Operating cash flowHUMA Free cash flowHUMA Capital expendituresHUMA Return on equityHUMA Stock buybacksHUMA Dividends paidHUMA Total assetsHUMA Total liabilitiesHUMA Shareholders’ equityHUMA overview →